yl23411永利(中国)有限公司-搜狗百科

This antibody has not been tested for use in all applications. This does not necessarily exclude its use in non-tested procedures. The stated dilutions are recommendations only. End users should determine optimal dilutions in their system using appropriate negative/positive controls.

Store at: 2-8 °C (lyophilized); - 20 °C (dissolved)

Repeated thawing and freezing must be avoided

References:

1. Karmatschek M, Maier I, Seibel MJ, Woitge HW, Ziegler R, Armbruster FP (1997). Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay. Clin Chem 43:2076-82.

2. Bellahcene A, Van Riet, I, de Greef C, Antoine N, Young MF, Van Camp B, Castronovo V (2000). Bone sialoprotein mRNA and protein expression in human multiple myeloma cell lines and patients. Br J Haematol 111:1118-21.

3. Adwan H, Bauerle T, Najajreh Y, Elazer V, Golomb G, Berger MR (2004). Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. Int J Oncol.24(5):1235-44.

4. KayedH, Kleeff J, Keleg S, Felix K,Giese T, Berger MR, Buchler MW, Friess H (2007). Effects of bone

sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Cancer Lett 245(1-2): 171-183.

For research use only